CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Big pharma-backed AdvanCell pockets $315m to progress RLT to Phase III

ADVC001Positive
AI Analysis

Summary

AdvanCell secured $315 million in funding to advance ADVC001 to Phase 3 and build radiopharmaceutical manufacturing infrastructure, backed by major pharmaceutical companies.

Clinical Trial Data

Phase

Phase 3

Importance:7/10
Sentiment:
0.70
financingradiopharmaceuticalPhase 3capital raise

Read the original article

Published by Pharmaceutical Technology on July 16, 2026 9:56 AM

Read Original